⌘K

Home/Filings/4/0001209191-16-109451

4//SEC Filing

Cidara Therapeutics, Inc. 4

Accession 0001209191-16-109451

$CDTXCIK 0001610618operating

View on SEC.gov Company Profile

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 4:02 PM ET

Size

5.4 KB

Accession

0001209191-16-109451

Insider Transaction Report

Form 4

Period: 2016-03-16

Cidara Therapeutics, Inc.CDTX

Chief Development Officer

Transactions

Award
Stock Option (right to buy)
2016-03-16+50,000→ 50,000 total
Exercise: $9.89Exp: 2026-03-15→ Common Stock (50,000 underlying)

Footnotes (1)

[F1]The option vests in 36 successive equal monthly installments over the three year period beginning on March 16, 2016.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Cidara Therapeutics, Inc.

CIK 0001610618

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001610618

Filing Metadata

Form type: 4
Filed: Mar 17, 8:00 PM ET
Accepted: Mar 18, 4:02 PM ET
Size: 5.4 KB

View on SEC.gov